Related Experiment Video
Updated: Jul 17, 2026

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
Published on: February 21, 2025
Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke
Bing-Qiao Zhao1, Emiri Tejima, Eng H Lo
1Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Abstract:
Matrix metalloproteinases (MMPs) mediate tissue injury during acute stroke. Clinical data show that elevated MMPs in plasma of stroke patients may correlate with outcomes, suggesting its use as a biomarker. MMP-9 signal has also been detected in clinical stroke brain tissue samples. Because tissue plasminogen activator can upregulate MMPs via lipoprotein receptor signaling, these neurovascular proteolytic events may underlie some of the complications of edema and hemorrhage that plague thrombolytic therapy. However, in contrast to its deleterious actions in acute stroke, MMPs and other neurovascular proteases may play beneficial roles during stroke recovery. MMPs are increased in the subventricular zone weeks after focal stroke, and inhibition of MMPs suppress neurogenic migration from subventricular zone into damaged tissue. In peri-infarct cortex, MMPs may mediate neurovascular remodeling. Delayed inhibition of MMPs decrease markers of remodeling, and these phenomena may be related to reductions in bioavailable growth factors. Acute versus chronic protease profiles within the neurovascular unit are likely to underlie critical responses to stroke, therapy, and recovery.
Insights
Matrix metalloproteinases (MMPs) play dual roles in stroke, causing injury acutely but aiding recovery by promoting neurogenesis and remodeling. Understanding these MMP roles is key for stroke treatment and recovery strategies.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Matrix metalloproteinases (MMPs) are implicated in acute stroke-related tissue injury.
- Elevated MMP levels in stroke patients may serve as a prognostic biomarker.
- MMP-9 has been detected in brain tissue samples from stroke patients.
Purpose of the Study:
- To investigate the dual role of MMPs in acute stroke injury and chronic stroke recovery.
- To explore the potential of MMPs as therapeutic targets or biomarkers in stroke.
Main Methods:
- Analysis of clinical data correlating plasma MMP levels with stroke outcomes.
- Detection of MMP-9 in clinical stroke brain tissue samples.
- Examination of MMP involvement in neurogenic migration and neurovascular remodeling post-stroke.
Main Results:
- MMPs contribute to acute stroke complications like edema and hemorrhage, potentially linked to thrombolytic therapy.
- MMPs are upregulated during stroke recovery, promoting neurogenic migration and neurovascular remodeling.
- Delayed MMP inhibition negatively impacts remodeling markers and growth factor bioavailability.
Conclusions:
- MMPs exhibit distinct roles in acute stroke versus chronic recovery phases.
- Protease activity within the neurovascular unit is critical for stroke response, therapy, and recovery.
- Targeting MMPs may offer therapeutic potential for stroke management and rehabilitation.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
